iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Stock Price Up 1.1%

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHEGet Free Report)’s stock price rose 1.1% during trading on Tuesday . The company traded as high as $64.08 and last traded at $63.92. Approximately 16,032 shares traded hands during mid-day trading, a decline of 78% from the average daily volume of 71,795 shares. The stock had previously closed at $63.25.

iShares U.S. Pharmaceuticals ETF Stock Performance

The stock’s 50-day simple moving average is $66.90 and its 200 day simple moving average is $62.83. The company has a market capitalization of $645.59 million, a PE ratio of 6.23 and a beta of 0.59.

Hedge Funds Weigh In On iShares U.S. Pharmaceuticals ETF

Several large investors have recently bought and sold shares of IHE. CX Institutional acquired a new position in shares of iShares U.S. Pharmaceuticals ETF during the 3rd quarter worth about $300,000. Stratos Wealth Advisors LLC acquired a new position in iShares U.S. Pharmaceuticals ETF in the third quarter valued at approximately $330,000. Apexium Financial LP purchased a new position in iShares U.S. Pharmaceuticals ETF in the third quarter valued at approximately $203,000. SteelPeak Wealth LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF during the third quarter worth approximately $208,000. Finally, NBC Securities Inc. acquired a new stake in iShares U.S. Pharmaceuticals ETF during the third quarter worth approximately $38,000.

iShares U.S. Pharmaceuticals ETF Company Profile

(Get Free Report)

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.

Further Reading

Receive News & Ratings for iShares U.S. Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.